NBIX
NEUROCRINE BIOSCIENCES INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$136.98
+0.94%Forward multiples
Based on analyst estimates
- P/E forward
- 14.97x
- P/E 2026E
- 19.13x
- P/E 2027E
- 14.00x
- P/E 2028E
- 11.00x
- P/S forward
- 3.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.43x
- PEG TTM
- 0.65x
- Price / book
- 3.77x
- Price / sales
- 4.13x
- Price / cash flow
- 15.50x
Enterprise value
- Enterprise value
- $13.9B
- EV / sales
- 4.13x
- EV / EBITDA
- 15.18x
- EV / EBIT
- 17.66x
- Market cap
- $13.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026